This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: British Columbia Cancer Agency Branch, Hospital Clinic De Barcelona, Julius-Maximilians-University of Wurzburg. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 66 
2 out of 26 
2 out of 6 
Years Active: 2018-2021
Title: **Andrew T Lister: Innovator in Cancer Prognostics**
Introduction
Andrew T Lister is a prominent inventor based in London, GB, known for his contributions to the field of cancer research. With a total of two patents to his name, his work focuses primarily on improving the prognostic tools available for patients suffering from diffuse large B cell lymphoma (DLBCL).
Latest Patents
Lister's latest patents include a groundbreaking invention titled "Survival Predictor for Diffuse Large B Cell Lymphoma." This invention provides innovative methods and materials related to a gene expression-based survival predictor for DLBCL patients. By harnessing the power of genetic information, his invention aims to enhance the accuracy of prognosis for individuals battling this aggressive form of cancer.
Career Highlights
Throughout his career, Andrew T Lister has made significant contributions in esteemed institutions. He has worked with the United States of America as represented by the Secretary of the Department of Health and Human Services and the University of Arizona. His experience in these organizations has undoubtedly enriched his inventive journey and broadened his impact on healthcare solutions.
Collaborations
Lister has collaborated with notable researchers such as Erlend B Smeland and Harald Holte. These partnerships have allowed him to engage in shared knowledge and drive innovative advancements in cancer prognosis, amplifying the potential benefits for patients.
Conclusion
In summary, Andrew T Lister stands out as a key figure in the innovation landscape of cancer research. His dedication to improving patient outcomes through innovative survival predictors showcases his commitment to advancing medical science. With his patents laying a foundation for future developments, Lister's work continues to inspire progress in the realm of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile